
Study found anti-VEGF therapy was linked to kidney function decline in patients with diabetic retinopathy or retinal vein occlusion.

Manju Subramanian, MD, is a board-certified ophthalmic surgeon specializing in vitreoretinal disease and associate professor at Boston University.